| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $17.1M | -26.3% |
| R&D Expense | $12.9M | +31.5% |
| SG&A Expense | $26.8M | +49.9% |
| Operating Income | -$63.2M | -33.8% |
| Pre-tax Income | -$61.4M | +16.4% |
| Income Tax | -$576K | -733.0% |
| Net Income | -$60.8M | +17.3% |
| EPS (Basic) | -$1.43 | +63.7% |
| EPS (Diluted) | -$1.43 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $27.1M | -84.8% |
| Accounts Receivable | $5.4M | +7.3% |
| Inventory | $21.2M | +35.2% |
| Current Assets | $138.6M | -36.5% |
| Total Assets | $190.7M | -20.9% |
| Current Liabilities | $19.1M | +4.9% |
| Long-term Debt | $0 | — |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$58.5M | -6.5% |
| Capital Expenditures | $6.7M | +109.5% |
| Investing Cash Flow | -$93.5M | -603.4% |
| Financing Cash Flow | $693K | -99.7% |
| Free Cash Flow | -$65.3M | -12.2% |
| +63.7% |
| Total Liabilities |
| $26.5M |
| +31.2% |
| Stockholders' Equity | $164.2M | -25.7% |